Scholarlink

<p>Cyclophosphamide treatment during chemotherapy can harm the ovaries and result in infertility in females. Idebenone, a synthetic antioxidant, has protective properties in various cells and tissues. This study aimed to investigate whether pre- and post-treatments with idebenone could help preserve the function and structure of rat ovaries in the face of the side effects of cyclophosphamide treatment.&#xa0;Female Wistar rats were divided into four groups: vehicle, cyclophosphamide control, idebenone pre-treatment, and idebenone post-treatment. Treatments lasted 14 days, followed by evaluation of superoxide dismutase (SOD) activity, malondialdehyde (MDA) and anti-Mullerian hormone (AMH) levels, ovarian follicle counts, and expression of GDF9, Bcl-2, and Bax proteins.&#xa0;The results of SOD activity, MDA and AMH levels, number of follicles, and expression of proteins GDF9, Bcl-2, and Bax were significantly more favorable in the experimental groups compared to the control group, and pre-treatment with idebenone was more effective than post-treatment.&#xa0;The results indicate that idebenone may mitigate the side effects of cyclophosphamide on the ovary, thereby improving its function and structure by reducing oxidative stress and apoptosis.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Effects of Pre- and Post-treatment of Idebenone on the Side Effects of the Chemotherapy Model with Cyclophosphamide in the Rat Ovary

  • 期刊论文

  • 发表日期：

    2026年4月22日

查看全文
  • Atefeh Doostmohammadi,
  • Manouchehr Safari,
  • Ali Ghanbari,
  • Parisa Hayat,
  • Athar Talebi,
  • Nooshin Ahmadirad,
  • Elham Salarmanesh,
  • Sam Zarbakhsh

摘要

Cyclophosphamide treatment during chemotherapy can harm the ovaries and result in infertility in females. Idebenone, a synthetic antioxidant, has protective properties in various cells and tissues. This study aimed to investigate whether pre- and post-treatments with idebenone could help preserve the function and structure of rat ovaries in the face of the side effects of cyclophosphamide treatment. Female Wistar rats were divided into four groups: vehicle, cyclophosphamide control, idebenone pre-treatment, and idebenone post-treatment. Treatments lasted 14 days, followed by evaluation of superoxide dismutase (SOD) activity, malondialdehyde (MDA) and anti-Mullerian hormone (AMH) levels, ovarian follicle counts, and expression of GDF9, Bcl-2, and Bax proteins. The results of SOD activity, MDA and AMH levels, number of follicles, and expression of proteins GDF9, Bcl-2, and Bax were significantly more favorable in the experimental groups compared to the control group, and pre-treatment with idebenone was more effective than post-treatment. The results indicate that idebenone may mitigate the side effects of cyclophosphamide on the ovary, thereby improving its function and structure by reducing oxidative stress and apoptosis.